Alzamend Neuro, Inc.
ALZN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001677077
In the last 90 days, Alzamend Neuro, Inc. insiders filed 1 open-market purchase and 1 sale; 12 institutions reported holding it in 13F filings for Q2 2026, worth $3.26M in total; no superinvestor holds it.
13F holders, Q3 2022
Institutional positions in Alzamend Neuro, Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 17
- −4 vs. Q2 2022
- Shares held
- 7.94M
- +4.84M (+156.6%) vs. Q2 2022
- Total value
- $9.41M
- +$6.71M (+248.9%) vs. Q2 2022
- New holders
- 5
- 3 more added
- Sold out
- 9
- 3 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ALZN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 12 | $3.26M |
| Q1 2026 | 13 | $723.1K |
| Q4 2025 | 13 | $447.2K |
| Q3 2025 | 11 | $351.3K |
| Q2 2025 | 7 | $6.36K |
| Q1 2025 | 11 | $59.9K |
| Q4 2024 | 17 | $131.7K |
| Q3 2024 | 12 | $71.2K |
| Q2 2024 | 16 | $150.5K |
| Q1 2024 | 13 | $386.8K |
| Q4 2023 | 16 | $334.7K |
| Q3 2023 | 27 | $1.49M |
| Q2 2023 | 24 | $3.13M |
| Q1 2023 | 26 | $2.64M |
| Q4 2022 | 33 | $3.98M |
| Q3 2022 | 17 | $9.41M |
| Q2 2022 | 21 | $2.70M |
| Q1 2022 | 22 | $4.01M |
| Q4 2021 | 20 | $1.66M |
| Q3 2021 | 17 | $1.99M |
| Q2 2021 | 11 | $2.58M |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Alzamend Neuro, Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 4,095,775 | $4.87M | 0.00% | +4,035,028+6,642.3% | Added |
| Truist Financial Corp | 2,314,907 | $2.75M | 0.01% | 00.0% | Unchanged |
| BlackRock Inc. | 596,129 | $709.0K | 0.00% | +596,129 | New |
| Geode Capital Management, LLC | 525,750 | $625.0K | 0.00% | +485,163+1,195.4% | Added |
| RFG Advisory, LLC | 250,000 | $270.0K | 0.02% | 00.0% | Unchanged |
| Group One Trading, L.P. | 45,523 | $54.0K | 0.00% | +33,821+289.0% | Added |
| Northern Trust Corp | 42,911 | $51.0K | 0.00% | +42,911 | New |
| UBS Group AG | 18,403 | $22.0K | 0.00% | −1,879−9.3% | Reduced |
| Commonwealth Equity Services, LLC | 16,666 | $19.0K | 0.00% | 00.0% | Unchanged |
| Dark Forest Capital Management LP | 11,344 | $13.0K | 0.00% | +11,344 | New |
| Insight Wealth Strategies, LLC | 10,000 | $9.00K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 3,700 | $4.00K | 0.00% | −200−5.1% | Reduced |
| Bank of America Corp | 1,686 | $2.00K | 0.00% | −6−0.4% | Reduced |
| Harbor Investment Advisory, LLC | 1,715 | $2.00K | 0.00% | 00.0% | Unchanged |
| Benjamin Edwards Inc | 1,000 | $1.00K | 0.00% | +1,000 | New |
| Money Concepts Capital Corp | 250 | $0 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 380 | $0 | 0.00% | +380 | New |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −101,646−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −83,950−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −65,131−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −49,223−100.0% | Sold out |
| Kingsbury Capital Investment Advisors LLC | 0 | $0 | 0.00% | −25,059−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −15,458−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −15,266−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −2,000−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −2,701−100.0% | Sold out |